Evodenoson

DB12295InvestigationalSmall molecule

Evodenoson has been used in trials studying the treatment of Open-angle Glaucoma and Ocular Hypertension.

Mechanism: Pharmacologically active on Adenosine receptor A2a
Curator reviewed
Formula / weight: C₂₃H₂₉N₇O₆ · 499.528 g/mol (avg)
Code names: ATL-313 · DE-112

Resolves to

Compound

Structure

InChIKeySQJXTUJMBYVDBB-RQXXJAGISA-NSMILESCOC(=O)N1CCC(CC#CC2=NC(N)=C3N=CN([C@@H]4O[C@@H]([C@@H](O)[C@H]4O)C(=O)NC4CC4)C3=N2)CC1

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Evodenoson, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.